The Fourth Affiliated Hospital of China Medical University
10
4
4
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
Role: collaborator
A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts
Role: lead
A Novel Fluorescent Ductal Needle for Localization and Sampling of High-risk Breast Micro Lesions
Role: lead
A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge
Role: lead
Evaluation of Vascular Structure in Elderly Using High-frequency Ultrasound and Construction of a Multimodal Risk Assessment System for Cardiovascular Diseases: a Multicenter Study
Role: collaborator
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Role: collaborator
HPA Antibodies and the Distribution of Antigen and Antibodies
Role: collaborator
Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China
Role: collaborator
Interstitial Lung Diseases Cohort Study in China
Role: collaborator
Anterior Transversalis Fascia Approach Versus Preperitoneal Space Approach for Inguinal Hernia Repair in Residents
Role: lead
All 10 trials loaded